نتائج البحث - Joseph Markowitz

تنقيح النتائج
  1. 1
    Review of S100A9 biology and its role in cancer

    Review of S100A9 biology and its role in cancer حسب Joseph Markowitz, William E. Carson

    منشور في 2012
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Factors affecting the slope of empirical ROC curves: Comparison of binary and rating responses

    Factors affecting the slope of empirical ROC curves: Comparison of binary and rating responses حسب Joseph Markowitz, John A. Swets

    منشور في 1967
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer

    Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer حسب Robert Wesolowski, Joseph Markowitz, William E. Carson

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The role of nitric oxide in melanoma

    The role of nitric oxide in melanoma حسب Keerthi Yarlagadda, John Hassani, Isaac P. Foote, Joseph Markowitz

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Myeloid-derived suppressor cells in breast cancer

    Myeloid-derived suppressor cells in breast cancer حسب Joseph Markowitz, Robert Wesolowski, Tracey L. Papenfuss, Taylor Brooks, William E. Carson

    منشور في 2013
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Inhibiting S100B Restores p53 Levels in Primary Malignant Melanoma Cancer Cells

    Inhibiting S100B Restores p53 Levels in Primary Malignant Melanoma Cancer Cells حسب Jing Lin, Qingyuan Yang, Zhe Yan, Joseph Markowitz, Paul T. Wilder, France Carrier, David J. Weber

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease

    Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease حسب Joseph Markowitz, Taylor Brooks, Megan Duggan, Bonnie Paul, Xueliang Pan, Lai Wei, Zachary B. Abrams, Eric Luedke, Gregory B. Lesinski, Bethany L. Mundy-Bosse, Tanios Bekaii‐Saab, William E. Carson

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients

    Circulating tumor DNA‐based molecular residual disease detection for treatment monitoring in advanced melanoma patients حسب Zeynep Eroglu, Shifra Krinshpun, Ekaterina Kalashnikova, Sumedha Sudhaman, Turkan Ozturk Topcu, Matt Nichols, Justin Martin, Katherine Bui, Charuta C. Palsuledesai, Meenakshi Malhotra, Perry Olshan, Joseph Markowitz, Nikhil I. Khushalani, Ahmad A. Tarhini, Jane L. Messina, Alexey Aleshin

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors

    Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors حسب Ben Creelan, Dmitry I. Gabrilovich, Jhanelle E. Gray, Charles C. Williams, Tawee Tanvetyanon, Eric B. Haura, Jeffrey S. Weber, Geoffrey T. Gibney, Joseph Markowitz, Joel W. Proksch, Scott A. Reisman, Mark D. McKee, Melanie Chin, Colin J. Meyer, Scott J. Antonia

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration

    Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration حسب Joseph Markowitz, Jiang Wang, Zach Vangundy, Jia You, Vedat Yildiz, Lianbo Yu, Isaac P. Foote, Owen E. Branson, Andrew Stiff, Taylor Brooks, Brandon J. Biesiadecki, Thomas Olencki, Susheela Tridandapani, Michael A. Freitas, Tracey L. Papenfuss, Mitch A. Phelps, William E. Carson

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice

    Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice حسب J. Kevin Hicks, Rachel Howard, Phillip Reisman, Jacob J. Adashek, Karen K. Fields, Jhanelle E. Gray, Bryan McIver, Kelly Johnston McKee, Mandy Flannery O’Leary, Randa Perkins, Edmondo Robinson, Ankita Tandon, Jamie K. Teer, Joseph Markowitz, Dana E. Rollison

    منشور في 2021
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma

    Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma حسب Pingyan Cheng, Xianghong Chen, Robert Dalton, Alexandra Calescibetta, Tina So, Danielle L. Gilvary, Grace Ward, Victoria Smith, Sterling Eckard, Judith A. Fox, Jeanmarie Guenot, Joseph Markowitz, John L. Cleveland, Kenneth L. Wright, Alan F. List, Sheng Wei, Erika A. Eksioglu

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer

    Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer حسب Robert Wesolowski, Megan Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha, Kala Levine, Lynn Schoenfield, Mahmoud Abdel‐Rasoul, Rachel M. Layman, Bhuvaneswari Ramaswamy, Erin Macrae, Maryam B. Lustberg, Raquel E. Reinbolt, Ewa Mrózek, John C. Byrd, Michael A. Caligiuri, Thomas A. Mace, William E. Carson

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

    Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma حسب John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran, Jeffrey S. Weber, Nikhil I. Khushalani, Zeynep Eroglu, Andrew S. Brohl, Joseph Markowitz, Erica Royster, Allison Richards, Valerie E. Stark, Jonathan S. Zager, Linda Kelley, Cheryl A. Cox, Vernon K. Sondak, James J. Mulé, Shari Pilon‐Thomas, Amod A. Sarnaik

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas

    A Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas حسب Tanios Bekaii‐Saab, Joseph Markowitz, Nichole Prescott, Wolfgang Sadée, Nyla A. Heerema, Lai Wei, Zunyan Dai, Audrey C. Papp, Angela Campbell, Kristy Culler, Catherine Balint, Bert H. O’Neil, Ruey-min Lee, Mark M. Zalupski, Janet Dancey, Helen Chen, Michael R. Grever, Charis Eng, Miguel A. Villalona‐Calero

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Combined BRAF and HSP90 Inhibition in Patients with Unresectable <i>BRAF</i>V600E-Mutant Melanoma

    Combined BRAF and HSP90 Inhibition in Patients with Unresectable <i>BRAF</i>V600E-Mutant Melanoma حسب Zeynep Eroglu, Y. Ann Chen, Geoffrey T. Gibney, Jeffrey S. Weber, Ragini R. Kudchadkar, Nikhil I. Khushalani, Joseph Markowitz, Andrew S. Brohl, Leticia Tetteh, Howida Ramadan, Gina Arnone, Jiannong Li, Xiuhua Zhao, Ritin Sharma, Lancia Darville, Bin Fang, Inna Smalley, Jane L. Messina, John M. Koomen, Vernon K. Sondak, Keiran S.M. Smalley

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma

    Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti–PD-1 Refractory Melanoma حسب Cara Haymaker, Daniel H. Johnson, Ravi Murthy, Salah-Eddine Bentebibel, Marc Uemura, Courtney W. Hudgens, Houssein Safa, Marihella James, Robert H.I. Andtbacka, Douglas B. Johnson, Montaser Shaheen, Michael A. Davies, Shah Rahimian, Srinivas K. Chunduru, Denái R. Milton, Michael T. Tetzlaff, Willem W. Overwijk, Patrick Hwu, Nashat Gabrail, Sudhir Agrawal, Gary C. Doolittle, Igor Puzanov, Joseph Markowitz, Chantale Bernatchez, Adi Diab

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma

    Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma حسب Douglas B. Johnson, Jennifer Bordeaux, Ju Young Kim, Christine Vaupel, David L. Rimm, Thai H. Ho, Richard W. Joseph, Adil Daud, Robert M. Conry, Elizabeth Gaughan, Leonel F. Hernandez‐Aya, Anastasios Dimou, Pauline Funchain, James W. Smithy, John S. Witte, Svetlana B. McKee, Jennifer S. Ko, John M. Wrangle, Bashar Dabbas, Shabnam Tangri, Jelveh Lameh, Jeffrey M. Hall, Joseph Markowitz, Justin M. Balko, Naveen Dakappagari

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities

    Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities حسب Zeynep Eroglu, Sheri L. Holmen, Qing Chen, Nikhil I. Khushalani, Ravi K. Amaravadi, Reena Thomas, Kamran A. Ahmed, Hussein A. Tawbi, Sunandana Chandra, Joseph Markowitz, Inna Smalley, James K. Liu, Y. Ann Chen, Yana G. Najjar, Florian A. Karreth, Daniel Abate‐Daga, Isabella C. Glitza, Jeffrey A. Sosman, Vernon K. Sondak, Marcus Bosenberg, Meenhard Herlyn, Michael B. Atkins, Harriet M. Kluger, Kim Margolin, Peter Forsyth, Michael A. Davies, Keiran S.M. Smalley

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy

    Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy حسب Daniel Lester, Chase Burton, Alycia Gardner, Patrick Innamarato, Krithika N. Kodumudi, Qian Liu, Emma Adhikari, Qianqian Ming, Daniel B. Williamson, Dennie T. Frederick, Tatyana Sharova, Michael G. White, Joseph Markowitz, Biwei Cao, Jonathan V. Nguyen, Joseph Johnson, Matthew Beatty, Andrea Mockabee‐Macias, Matthew Mercurio, G. Watson, Pei-Ling Chen, Susan McCarthy, Carlos Moran Segura, Jane L. Messina, Kerry Thomas, Lancia Darville, Victoria Izumi, John M. Koomen, Shari Pilon‐Thomas, Brian Ruffell, Vincent C. Luca, Robert S. Haltiwanger, Xuefeng Wang, Jennifer A. Wargo, Genevieve M. Boland, Eric K. Lau

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: